Pulse Biosciences, Inc. (PLSE)

Market Cap	1.13B
Revenue (ttm)	n/a
Net Income (ttm)	-60.24M
Shares Out	67.27M
EPS (ttm)	-0.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	189,244
Open	17.78
Previous Close	17.07
Day's Range	16.74 - 17.89
52-Week Range	6.66 - 25.00
Beta	1.60
Analysts	n/a
Price Target	n/a
Earnings Date	May 8, 2025

About PLSE

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-ena...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 18, 2016
• Employees: 75
• Stock Exchange: NASDAQ
• Ticker Symbol: PLSE
• Website: https://www.pulsebiosciences.com